Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Adverse drug reactions

Off-label use of sildenafil in valvular heart disease should be avoided

A study presented at the European Society of Cardiology Congress reported the effects of sildenafil in patients with valvular heart disease.

Sildenafil and Viagra tablets

Source: B. Boissonnet / BSIP / Science Photo Library

Researchers found that the clinical status of patients with residual pulmonary hypertension after valvular heart disease worsened in twice as many of those receiving sildenafil compared with those on placebo

Residual pulmonary hypertension (PH) is a common complication after correction of valvular heart disease (VHD), and is associated with poor outcomes. Sildenafil is sometimes used off-label in these patients but its efficacy has never been explored in a clinical trial.

In a study presented at the European Society of Cardiology Congress in Barcelona, researchers randomly assigned 200 patients with residual PH to daily sildenafil or placebo for six months[1].

They found that, based on a composite score, the clinical status of the patients worsened in twice as many of those receiving sildenafil compared with those on placebo (33% vs 15%). Major clinical events — death or readmission for heart failure — were also twice as likely to occur in the sildenafil group.

The team concluded that treatment with sildenafil in patients with residual PH after successful correction of VHD was associated with unfavourable clinical outcomes compared with placebo, and should be avoided in this group of patients.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203778

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Sildenafil and Viagra tablets

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.